Camtek (CAMT) HR head sells 508 shares, no 10b5-1 plan

Rhea-AI Filing Summary

CAMTEK LTD officer Orit Geva-Dvash, Vice President of HR, reported selling 508 Ordinary Shares of CAMT on 2026-08-17 in an open market or private transaction at $175.00 per share. Following this sale, she directly holds 5,205 Ordinary Shares. The Rule 10b5-1 trading-plan checkbox was not marked as used.

Insider Trade Summary

Net Seller: 508 shares

Net Sell 1 txn

Insider Geva-Dvash Orit

Role Vice President, HR

Sold 508 shs ($89K)

Type	Security	Shares	Price	Value
Sale	Ordinary Shares	508	$175.00	$89K

Holdings After Transaction: Ordinary Shares — 5,205 shares (Direct)

Key Figures

Shares sold: 508 Ordinary Shares Sale price per share: $175.0000 Shares held after transaction: 5205 Ordinary Shares +1 more

4 metrics

Shares sold 508 Ordinary Shares Non-derivative sale on 2026-08-17

Sale price per share $175.0000 Price per Ordinary Share in reported sale

Shares held after transaction 5205 Ordinary Shares Direct ownership following the sale

Net shares sold 508 shares Net buy/sell shares in transaction summary

Key Terms

Ordinary Shares, open market or private transaction, Rule 10b5-1

3 terms

Ordinary Shares financial

"security_title: "Ordinary Shares""

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

open market or private transaction financial

"transaction_code_description: "Sale in open market or private transaction""

Rule 10b5-1 regulatory

"Rule 10b5-1 trading-plan checkbox was not marked as used"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

FAQ

What insider transaction did CAMT executive Orit Geva-Dvash report?

Orit Geva-Dvash reported a sale of 508 Ordinary Shares of CAMTEK LTD on 2026-08-17 at $175.00 per share in an open market or private transaction.

How many CAMT shares did Orit Geva-Dvash retain after the reported sale?

After the transaction, Orit Geva-Dvash directly held 5,205 Ordinary Shares of CAMTEK LTD, as disclosed in the Form 4’s post-transaction ownership figure.

Was Orit Geva-Dvash’s CAMT stock sale made under a Rule 10b5-1 plan?

The filing’s Rule 10b5-1 checkbox is unchecked, indicating the reported sale was not affirmed as made under a Rule 10b5-1 trading plan.

What price did Orit Geva-Dvash receive per CAMT share sold?

The reported transaction price was $175.00 per Ordinary Share for the 508 shares sold on 2026-08-17, characterized as an open market or private transaction.

What position does Orit Geva-Dvash hold at CAMTEK LTD (CAMT)?

Orit Geva-Dvash is an officer of CAMTEK LTD, serving as Vice President, HR, according to the role information disclosed in the Form 4.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/18/2026 - 07:39 AM Accepted by SEC EDGAR 08/18/2026 - 07:39 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Geva-Dvash Orit

(Last) (First) (Middle)

EXODUS 6

(Street)

ZICHRON YAAKOV

(City) (State) (Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
CAMTEK LTD [ CAMT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Vice President, HR

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	08/17/2026		S		508	D	$175	5,205	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Meirav Shemesh on behalf of Oppenheimer Israel, as Attorney-in-fact	08/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)